U.S. Poultry Medicine Market Size, Share & Trends Analysis Report By Species (Chicken, Turkey, Ducks), By Product (Biologics, Pharmaceuticals), By Disease Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025

The U.S. poultry medicine market size was estimated at USD 1.83 billion in 2024 and is projected to reach USD 3.11 billion by 2033, growing at a CAGR of 6.20% from 2025 to 2033. The market is continuously growing, driven by high poultry consumption and market value, a shift towards antibiotic alternatives, andtechnological advancements in poultry healthcare. According to the USDA Economic Research Service, U.S. poultry products dominate both domestic and global meat markets, due to efficient production systems, advanced genetics, ample feed supply, and strong consumer demand. Between 2013 and 2022, broilers accounted for 67% of poultry sales, followed by eggs at 22% and turkeys at 11%, primarily for consumption.

This surge in demand for poultry products directly translates into the need for efficient and sustainable poultry farming practices, necessitating comprehensive healthcare solutions to maintain the health and productivity of poultry flocks. The per capita consumption of poultry, from 2020 to 2024, is illustrated below in the chart:

Growing concerns over antimicrobial resistance have prompted the U.S. poultry industry to reduce antibiotic use. Regulations like the Preservation of Antibiotics for Medical Treatment Act (PAMTA) and the Preventing Antibiotic Resistance Act (PARA) have restricted the use of medically important antibiotics in poultry and livestock. For decades, antibiotics have been widely used in livestock and poultry, as high-dose treatments for specific infections and as low-dose growth promoters in animal feed. In 2013, around 131,000 tons of antibiotics were used in food animals, a number projected to increase to nearly 200,000 tons by 2030 due to rising global demand. This shift has led to increased demand for alternative health management strategies, such as vaccines, probiotics, and herbal supplements, to ensure poultry health and productivity.

Advancements in veterinary and animal nutrition technologies have significantly impacted the U.S. poultry pharmaceuticals market. The development of new vaccines, diagnostic tools, feed supplements, and other specialized healthcare products has enabled poultry producers to address a wider range of health challenges, improve flock performance, and enhance food safety. These innovations contribute to more efficient and sustainable poultry farming practices.

U.S. Poultry Medicine Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. poultry medicine market report based on species, product, disease type, route of administration, and distribution channel:

Species Outlook (Revenue, USD Million, 2021 - 2033)
Chicken
- Broiler
- Layer
Turkey
Ducks
Others
Product Outlook (Revenue, USD Million, 2021 - 2033)
Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
Medicated Feed Additives
Disease Type Outlook (Revenue, USD Million, 2021 - 2033)
Newcastle Disease
Infectious Bronchitis
Infectious Bursal Disease
Coccidiosis
Salmonella
Marek's Disease
Others
Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
Oral
Injectable
Topical
Others
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Veterinary Hospitals & Clinics
E-commerce
Offline Retail Stores
Others

Product Code: GVR-4-68040-648-7

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.3.6. Data analysis model
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Volume price analysis
1.8. List of Secondary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. U.S. Poultry Medicine Market Variable Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. High poultry consumption and market value
  - 3.2.1.2. Shift towards antibiotic alternatives
  - 3.2.1.3. Technological advancements in poultry healthcare
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Stringent regulatory compliance and approval processes
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
3.3. U.S. Poultry Medicine Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitution
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Legal landscape
  - 3.3.2.3. Economic landscape
  - 3.3.2.4. Social landscape
  - 3.3.2.5. Technological landscape
  - 3.3.2.6. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Pricing Analysis
- 3.3.5. Product Pipeline Analysis
- 3.3.6. Estimated Poultry Population in U.S., 2024

Chapter 4. U.S. Poultry Medicine Market: Species Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. U.S. Poultry Medicine Market: Species, market share 2024 & 2033
4.3. U.S. Poultry Medicine Market Size & Trend Analysis, by species, 2021 to 2033 (USD Million)
4.4. Chicken
- 4.4.1. Chicken Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.1. Broiler
    - 4.4.1.1.1. Broiler Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.2. Layer
    - 4.4.1.2.1. Layer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Turkey
- 4.5.1. Turkey Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Ducks
- 4.6.1. Ducks Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Others
- 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Poultry Medicine Market: Disease Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. U.S. Poultry Medicine Market: Disease type, market share 2024 & 2033
5.3. U.S. Poultry Medicine Market Size & Trend Analysis, by Disease Type, 2021 to 2033 (USD Million)
5.4. Newcastle Disease
- 5.4.1. Newcastle Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Infectious Bronchitis
- 5.5.1. Infectious Bronchitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Infectious Bursal Disease
- 5.6.1. Infectious Bursal Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Coccidiosis
- 5.7.1. Coccidiosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Salmonella
- 5.8.1. Salmonella Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Marek's Disease
- 5.9.1. Marek's Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.10. Others
- 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Poultry Medicine Market: Product Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. U.S. Poultry Medicine Market: Product, market share 2024 & 2033
6.3. U.S. Poultry Medicine Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
6.4. Biologics
- 6.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. Vaccines
  - 6.4.2.1. Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    - 6.4.2.1.1. Modified/ Attenuated Live
      - 6.4.2.1.1.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    - 6.4.2.1.2. Inactivated (Killed)
      - 6.4.2.1.2.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    - 6.4.2.1.3. Other Vaccines
      - 6.4.2.1.3.1. Other Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Other Biologics
  - 6.4.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Pharmaceuticals
- 6.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Parasiticides
  - 6.5.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Anti-infectives
  - 6.5.3.1. Anti-infectives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.4. Anti-inflammatory
  - 6.5.4.1. Anti-inflammatory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.5. Analgesics
  - 6.5.5.1. Analgesics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.6. Others
  - 6.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Medicated Feed Additives
- 6.6.1. Medicated Feed Additives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Poultry Medicine Market: By Route of Administration Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. U.S. Poultry Medicine Market: By Route of Administration, market share 2024 & 2033
7.3. U.S. Poultry Medicine Market Size & Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
- 7.3.1. Oral
  - 7.3.1.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. Injectable
  - 7.3.2.1. Injectable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Topical
  - 7.3.3.1. Topical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Others
  - 7.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Poultry Medicine Market: By Distribution Channel Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. U.S. Poultry Medicine Market: By Distribution Channel, market share 2024 & 2033
8.3. U.S. Poultry Medicine Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 8.3.1. Veterinary Hospitals & Clinics
  - 8.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. E-commerce
  - 8.3.2.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Offline Retail Stores
  - 8.3.3.1. Offline Retail Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.4. Others
  - 8.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heat Map Analysis
9.3. Company Profiles
- 9.3.1. Boehringer Ingelheim International GmbH
  - 9.3.1.1. Participant's Overview
  - 9.3.1.2. Financial Performance
  - 9.3.1.3. Product Benchmarking
  - 9.3.1.4. Strategic Initiatives
- 9.3.2. Zoetis Services LLC
  - 9.3.2.1. Participant's Overview
  - 9.3.2.2. Financial Performance
  - 9.3.2.3. Product Benchmarking
  - 9.3.2.4. Strategic Initiatives
- 9.3.3. Vaxxinova International BV
  - 9.3.3.1. Participant's Overview
  - 9.3.3.2. Financial Performance
  - 9.3.3.3. Product Benchmarking
  - 9.3.3.4. Strategic Initiatives
- 9.3.4. Merck & Co., Inc.
  - 9.3.4.1. Participant's Overview
  - 9.3.4.2. Financial Performance
  - 9.3.4.3. Product Benchmarking
  - 9.3.4.4. Strategic Initiatives
- 9.3.5. Elanco
  - 9.3.5.1. Participant's Overview
  - 9.3.5.2. Financial Performance
  - 9.3.5.3. Product Benchmarking
  - 9.3.5.4. Strategic Initiatives
- 9.3.6. Ceva Sante Animale
  - 9.3.6.1. Participant's Overview
  - 9.3.6.2. Financial Performance
  - 9.3.6.3. Product Benchmarking
  - 9.3.6.4. Strategic Initiatives
- 9.3.7. Phibro Animal Health Corporation
  - 9.3.7.1. Participant's Overview
  - 9.3.7.2. Financial Performance
  - 9.3.7.3. Product Benchmarking
  - 9.3.7.4. Strategic Initiatives
- 9.3.8. Virbac
  - 9.3.8.1. Participant's Overview
  - 9.3.8.2. Financial Performance
  - 9.3.8.3. Product Benchmarking
  - 9.3.8.4. Strategic Initiatives
- 9.3.9. Hipra
  - 9.3.9.1. Participant's Overview
  - 9.3.9.2. Financial Performance
  - 9.3.9.3. Product Benchmarking
  - 9.3.9.4. Strategic Initiatives
- 9.3.10. Vetanco
  - 9.3.10.1. Participant's Overview
  - 9.3.10.2. Financial Performance
  - 9.3.10.3. Product Benchmarking
  - 9.3.10.4. Strategic Initiatives
- 9.3.11. Kemin Industries, Inc
  - 9.3.11.1. Participant's Overview
  - 9.3.11.2. Financial Performance
  - 9.3.11.3. Product Benchmarking
  - 9.3.11.4. Strategic Initiatives
9.4. Strategy Mapping
- 9.4.1. Mergers & Acquisitions
- 9.4.2. Partnerships & Collaborations
- 9.4.3. Product launch
- 9.4.4. Others
9.5. List of other key players

Product Code: GVR-4-68040-648-7

List of Tables

Table 1 List of secondary sources
Table 2 U.S. Poultry Medicine Market, by Species, 2021 - 2033 (USD Million)
Table 3 U.S. Poultry Medicine Market, by Product, 2021 - 2033 (USD Million)
Table 4 U.S. Poultry Medicine Market, by Disease Type, 2021 - 2033 (USD Million)
Table 5 U.S. Poultry Medicine Market, by Route of Administration, 2021 - 2033 (USD Million)
Table 6 U.S. Poultry Medicine Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 7 Company Overview
Table 8 Product Benchmarking
Table 9 Financial Performance
Table 10 Strategic Initiatives

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. Poultry Medicine Market revenue, 2021-2033 (USD Million)
Fig. 10 U.S. Poultry Medicine Market snapshot
Fig. 11 U.S. Poultry Medicine Market driver impact
Fig. 12 U.S. Poultry Medicine Market restraint impact
Fig. 13 U.S. Poultry Medicine species key takeaways (USD Million)
Fig. 14 U.S. Poultry Medicine Market: species, market share, 2024 & 2033
Fig. 15 Chicken market, 2021 - 2033 (USD Million)
Fig. 16 Broiler market, 2021 - 2033 (USD Million)
Fig. 17 Layer market, 2021 - 2033 (USD Million)
Fig. 18 Turkey market, 2021 - 2033 (USD Million)
Fig. 19 Ducks market, 2021 - 2033 (USD Million)
Fig. 20 Others market, 2021 - 2033 (USD Million)
Fig. 21 U.S. Poultry Medicine disease type key takeaways (USD Million)
Fig. 22 U.S. Poultry Medicine Market: disease type, market share, 2024 & 2033
Fig. 23 Newcastle Disease market, 2021 - 2033 (USD Million)
Fig. 24 Infectious Bronchitis market, 2021 - 2033 (USD Million)
Fig. 25 Infectious Bursal Disease market, 2021 - 2033 (USD Million)
Fig. 26 Coccidiosis market, 2021 - 2033 (USD Million)
Fig. 27 Salmonella market, 2021 - 2033 (USD Million)
Fig. 28 Marek's Disease market, 2021 - 2033 (USD Million)
Fig. 29 Others market, 2021 - 2033 (USD Million)
Fig. 30 U.S. Poultry Medicine Market Product key takeaways (USD Million)
Fig. 31 U.S. Poultry Medicine Market: Product, market share, 2024 & 2033
Fig. 32 Biologics market, 2021 - 2033 (USD Million)
Fig. 33 Vaccine market, 2021 - 2033 (USD Million)
Fig. 34 Modified/attenuated live market, 2021 - 2033 (USD Million)
Fig. 35 Inactivated (killed) market, 2021 - 2033 (USD Million)
Fig. 36 Other vaccines market, 2021 - 2033 (USD Million)
Fig. 37 Other Biologics market, 2021 - 2033 (USD Million)
Fig. 38 Pharmaceuticals market, 2021 - 2033 (USD Million)
Fig. 39 Parasiticides market, 2021 - 2033 (USD Million)
Fig. 40 Anti-infectives market, 2021 - 2033 (USD Million)
Fig. 41 Anti-inflammatory market, 2021 - 2033 (USD Million)
Fig. 42 Analgesics market, 2021 - 2033 (USD Million)
Fig. 43 Others market, 2021 - 2033 (USD Million)
Fig. 44 Medicated feed additives market, 2021 - 2033 (USD Million)
Fig. 45 U.S. Poultry Medicine market by route of administration: Key takeaways
Fig. 46 U.S. Poultry Medicine market by route of administration, market share, 2024 & 2033
Fig. 47 Oral market, 2021 - 2033 (USD Million)
Fig. 48 Injectable market, 2021 - 2033 (USD Million)
Fig. 49 Topical market, 2021 - 2033 (USD Million)
Fig. 50 Others market, 2021 - 2033 (USD Million)
Fig. 51 U.S. Poultry Medicine market by Distribution Channel: Key takeaways
Fig. 52 U.S. Poultry Medicine market by Distribution Channel, market share, 2024 & 2033
Fig. 53 Veterinary hospitals & clinics market, 2021 - 2033 (USD Million)
Fig. 54 E-commerce market, 2021 - 2033 (USD Million)
Fig. 55 Offline retail stores market, 2021 - 2033 (USD Million)
Fig. 56 Others market, 2021 - 2033 (USD Million)
Fig. 57 Market participant categorization
Fig. 58 Market share of key market players U.S. Poultry Medicine market

U.S. Poultry Medicine Market Size, Share & Trends Analysis Report By Species (Chicken, Turkey, Ducks), By Product (Biologics, Pharmaceuticals), By Disease Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2033

Description

Table of Contents

List of Tables

Market Size & Trends:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Poultry Medicine Market Variable Trends & Scope

Chapter 4. U.S. Poultry Medicine Market: Species Estimates & Trend Analysis

Chapter 5. U.S. Poultry Medicine Market: Disease Type Estimates & Trend Analysis

Chapter 6. U.S. Poultry Medicine Market: Product Estimates & Trend Analysis

Chapter 7. U.S. Poultry Medicine Market: By Route of Administration Estimates & Trend Analysis

Chapter 8. U.S. Poultry Medicine Market: By Distribution Channel Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures